StockDocs
Main Newswire Learn
Project by Matthew Castle Please send feedback to matthewgcastle@gmail.com
SNDL

SNDL Inc.

SNDL Nasdaq Medicinal Chemicals & Botanical Products EDGAR ↗
$1.36
-0.03 -2.16%

Key statistics

from XBRL data in SEC filings
Market cap ⓘ
$358M
Revenue (TTM) ⓘ
—
Net income (TTM) ⓘ
—
EPS (TTM) ⓘ
—
P/E ratio ⓘ
—
Dividend yield ⓘ
—
Free cash flow ⓘ
—
Cash ⓘ
—
Total assets ⓘ
—
Gross margin ⓘ
—
52-week range ⓘ
$1.17 – $2.89

AI briefing

from the latest 10-K, 10-Q and 8-K events

SNDL Inc. is a Canadian cannabis and liquor retailer with production and investment operations, listed on NASDAQ under ticker SNDL.

What they do

SNDL operates through three reportable segments: Cannabis Retail, Cannabis Operations, and Liquor Retail. Its cannabis retail segment sells recreational cannabis through retail stores, while the liquor retail segment, largely from the Alcanna acquisition, operates liquor stores. The cannabis operations segment produces and sells cannabis for medical and recreational use.

Revenue drivers

  • Cannabis Retail — Generates revenue from the sale of recreational cannabis products through retail stores. This segment is a primary revenue source, with revenue reported for 2020 and 2021.
  • Liquor Retail — Derives revenue from the sale of liquor products through retail stores, following the acquisition of Alcanna Inc. in 2022. The segment includes retail liquor operations.
  • Cannabis Operations — Earns revenue from the cultivation, production, and sale of cannabis, including medical cannabis. Revenue is reported for 2020, 2021, and 2022.
  • Investment Segment — Generates income from investments in other companies, such as SunStream Bancorp Inc. and Valens, through interest, dividends, or fair value changes.

Recent performance

The filing excerpts do not contain specific financial results for revenue, net income, or cash flow for the most recent periods. Revenue is presented for 2020, 2021, and 2022, but no figures are disclosed in the provided data. Segment revenue data is tagged for Cannabis Retail, Liquor Retail, and Cannabis Operations, but values are not included in the excerpts. Therefore, a detailed performance summary cannot be provided from the available information.

Strategy

SNDL's strategy appears focused on growth through acquisitions, as evidenced by the acquisition of Alcanna Inc. in 2022 and the arrangement with Valens in 2022. The company operates in three segments: cannabis retail, cannabis operations, and liquor retail, indicating a diversified approach. It also holds investments in other entities, such as SunStream Bancorp Inc. The filing mentions various financial instruments and warrants, suggesting active capital management. No explicit strategy statements are available in the excerpts.

Risks

  • Regulatory Risk — As a Canadian cannabis company, SNDL is subject to extensive regulation, including licensing, product standards, and taxation, which could change and adversely affect operations.
  • Integration Risk — The company's acquisitions, such as Alcanna Inc., involve integration challenges that could disrupt operations and fail to achieve expected synergies.
  • Competition — The cannabis and liquor retail markets are highly competitive, with many players, which could pressure margins and market share.
  • Financial Instrument Risk — The company has significant derivative warrant liabilities and investments at fair value, exposing it to market volatility and potential losses.

Outlook

The filing excerpts do not include management's forward-looking statements or outlook. Therefore, no outlook can be provided based on the available information.